Robert Zivadinov

99PUBLICATIONS
94CO-AUTHORS
Preventative health careNeurology and neuromuscular diseasesMolecular targetsMicroelectromechanical systems (MEMS)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (99)

|Jul 10, 2026
Preventing frailty in multiple sclerosis is a realistic goal-Commentary.

|Jul 01, 2026
Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.

|Apr 06, 2026
Dura mater enhancement on 3T MRI is associated with cortical lesion burden in multiple sclerosis.

Robert Zivadinov, Mehak Semy, Alexander Bartnik

|Feb 18, 2026
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.

Aaron Miller, Jeffrey A Cohen, Arnon Karni

Pageof 17